Cytosorbents (CTSO) 2025 Earnings Outlook for Investors
Investors are weighing the beads-and-blood-screening company Cytosorbents as it reports 2025 earnings. This guide bre...
Discover various ways to diversify your income sources, increasing your earning potential and financial resilience.
20,225 articlesInvestors are weighing the beads-and-blood-screening company Cytosorbents as it reports 2025 earnings. This guide bre...
Resideo Technologies stock slid after its quarterly update, underscoring how guidance and costs matter as the company...
CrowdStrike stock just 52-week highs signal strong momentum, but investors must weigh the run-up against real growth....
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Fox stock is down after announcing a Roku deal, leaving investors weighing value vs risk. This guide breaks down the ...
Two software leaders battle for your 2026 portfolio: Duolingo and Zeta Global. This guide compares business models, g...
July 16 could be a pivotal date for Nvidia and the broader AI chip ecosystem. This guide explains why Nvidia investor...
Jaguar Land Rover is recalling roughly 2,300 US-registered I-Pace electric SUVs due to a high-voltage battery fire ri...
A major investor stepped into Crocs with a sizable new stake, valuing the position at about $53.7 million even as CRO...
TransMedics has surged 104% over the last year, catching investors’ eyes. This guide breaks down the business, the ca...
Tech stocks aren’t falling because of headlines about conflicts. The bigger driver is AI infrastructure capex and mac...
AI is reshaping the data center landscape, and Marvell is at the center of the action. This piece breaks down why mar...